Suppr超能文献

原位肝移植术中失血:预测因素

Intraoperative blood loss in orthotopic liver transplantation: The predictive factors.

作者信息

Pandey Chandra Kant, Singh Anshuman, Kajal Kamal, Dhankhar Mandeep, Tandon Manish, Pandey Vijay Kant, Karna Sunaina Tejpal

机构信息

Chandra Kant Pandey, Anshuman Singh, Kamal Kajal, Mandeep Dhankhar, Manish Tandon, Vijay Kant Pandey, Sunaina Tejpal Karna, Department of Anaesthesiology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi 110070, India.

出版信息

World J Gastrointest Surg. 2015 Jun 27;7(6):86-93. doi: 10.4240/wjgs.v7.i6.86.

Abstract

Liver transplantation has been associated with massive blood loss and considerable transfusion requirements. Bleeding in orthotopic liver transplantation is multifactorial. Technical difficulties inherent to this complex surgical procedure and pre operative derangements of the primary and secondary coagulation system are thought to be the principal causes of perioperative hemorrhage. Intraoperative practices such as massive fluid resuscitation and resulting hypothermia and hypocalcemia secondary to citrate toxicity further aggravate the preexisting coagulopathy and worsen the perioperative bleeding. Excessive blood loss and transfusion during orthotopic liver transplant are correlated with diminished graft survival and increased septic episodes and prolonged ICU stay. With improvements in surgical skills, anesthetic technique, graft preservation, use of intraoperative cell savers and overall perioperative management, orthotopic liver transplant is now associated with decreased intra operative blood losses. The purpose of this review is to discuss the risk factors predictive of increased intra operative bleeding in patients undergoing orthotopic liver transplant.

摘要

肝移植与大量失血和大量输血需求相关。原位肝移植中的出血是多因素的。这种复杂手术程序固有的技术困难以及原发性和继发性凝血系统的术前紊乱被认为是围手术期出血的主要原因。术中大量液体复苏以及由此导致的低温和柠檬酸盐毒性继发的低钙血症等操作进一步加重了已有的凝血功能障碍,并使围手术期出血恶化。原位肝移植期间的过量失血和输血与移植肝存活率降低、感染性并发症增加以及重症监护病房(ICU)住院时间延长相关。随着手术技巧、麻醉技术、移植物保存、术中血液回收器的使用以及整体围手术期管理的改进,原位肝移植目前术中失血量减少。本综述的目的是讨论预测原位肝移植患者术中出血增加的危险因素。

相似文献

1
Intraoperative blood loss in orthotopic liver transplantation: The predictive factors.
World J Gastrointest Surg. 2015 Jun 27;7(6):86-93. doi: 10.4240/wjgs.v7.i6.86.
2
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation.
Anesthesiology. 1996 Nov;85(5):1043-8; discussion 30A-31A. doi: 10.1097/00000542-199611000-00012.
4
Liver transplantation and risk of bleeding.
Curr Opin Organ Transplant. 2007 Jun;12(3):287-293. doi: 10.1097/MOT.0b013e32814e6bb0.
6
Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation.
Eur J Gastroenterol Hepatol. 2002 Aug;14(8):827-32. doi: 10.1097/00042737-200208000-00003.
7
Massive haemorrhage in liver transplantation: Consequences, prediction and management.
World J Transplant. 2016 Jun 24;6(2):291-305. doi: 10.5500/wjt.v6.i2.291.
8
Transfusion practice in orthotopic liver transplantation.
Indian J Crit Care Med. 2009 Jul-Sep;13(3):120-8. doi: 10.4103/0972-5229.58536.
9
Pharmacologic Strategies to Prevent Blood Loss and Transfusion in Orthotopic Liver Transplantation.
Crit Care Nurs Q. 2016 Jul-Sep;39(3):267-80. doi: 10.1097/CNQ.0000000000000120.
10
The Impact of Preoperative Variables on Intraoperative Blood Loss and Transfusion Requirements During Orthotopic Liver Transplant.
Exp Clin Transplant. 2019 Aug;17(4):507-512. doi: 10.6002/ect.2016.0325. Epub 2017 Oct 12.

引用本文的文献

1
Preventive correction of fibrinolysis with epsilon aminocaproic acid detected by thromboelastometry during liver transplantation.
Arq Bras Cir Dig. 2025 Aug 18;38:e1891. doi: 10.1590/0102-67202025000022e1891. eCollection 2025.
2
Impact of massive hemorrhage on outcome in patients with orthotopic liver transplant: A retrospective unicenter study.
Medicine (Baltimore). 2025 Jul 25;104(30):e43575. doi: 10.1097/MD.0000000000043575.
5
Patient sex and use of tranexamic acid in liver transplantation.
Front Med (Lausanne). 2024 Sep 23;11:1452733. doi: 10.3389/fmed.2024.1452733. eCollection 2024.
6
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities.
Int J Mol Sci. 2024 May 28;25(11):5849. doi: 10.3390/ijms25115849.
9
Patient Blood Management in Liver Transplant-A Concise Review.
Biomedicines. 2023 Apr 4;11(4):1093. doi: 10.3390/biomedicines11041093.

本文引用的文献

2
Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center.
Transplantation. 2012 Jun 27;93(12):1276-81. doi: 10.1097/TP.0b013e318250fc25.
3
Methods to decrease blood loss and transfusion requirements for liver transplantation.
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD009052. doi: 10.1002/14651858.CD009052.pub2.
4
Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival.
Transplantation. 2011 Jun 15;91(11):1273-8. doi: 10.1097/TP.0b013e31821ab9f8.
5
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Ann Intern Med. 2011 Apr 19;154(8):529-40. doi: 10.7326/0003-4819-154-8-201104190-00004.
6
Veno-venous bypass versus none for liver transplantation.
Cochrane Database Syst Rev. 2011 Mar 16(3):CD007712. doi: 10.1002/14651858.CD007712.pub2.
7
Risk factors for bleeding and transfusion during orthotopic liver transplantation.
Ann Fr Anesth Reanim. 2011 Apr;30(4):349-52. doi: 10.1016/j.annfar.2011.01.008. Epub 2011 Feb 24.
9
Predictors of blood transfusion requirement in elective liver resection.
HPB (Oxford). 2010 Feb;12(1):50-5. doi: 10.1111/j.1477-2574.2009.00126.x.
10
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.
Blood. 2010 Aug 12;116(6):878-85. doi: 10.1182/blood-2010-02-261891. Epub 2010 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验